Flexibility in assessment of rare disease technologies via NICE’s single technology appraisal route: a thematic analysis
Aim: NICE’s highly specialized technology (HST) evaluations are highly restrictive in terms of entry criteria and as a consequence, the vast majority of rare disease medicines are assessed through NICE’s standard, single technology appraisal (STA) route. We explored whether NICE shows flexibility...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Becaris Publishing Limited
2023-09-01
|
| Series: | Journal of Comparative Effectiveness Research |
| Subjects: |